BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
1511 results:

  • 1. Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centers.
    Roohani S; Ehret F; Beck M; Veltsista DP; Nadobny J; Zschaeck S; Abdel-Rahman S; Eckert F; Flörcken A; Issels RD; Klöck S; Krempien R; Lindner LH; Notter M; Ott OJ; Pink D; Potkrajcic V; Reichardt P; Riesterer O; Spałek MJ; Stutz E; Wessalowski R; Zilli T; Zips D; Ghadjar P; Kaul D
    Int J Hyperthermia; 2024; 41(1):2342348. PubMed ID: 38653548
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas.
    Long Q; Li Z; Yang W; Huang K; Du G
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):203. PubMed ID: 38635069
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deep learning radiomics-based prediction model of metachronous distant metastasis following curative resection for retroperitoneal leiomyosarcoma: a bicentric study.
    Tian Z; Cheng Y; Zhao S; Li R; Zhou J; Sun Q; Wang D
    Cancer Imaging; 2024 Apr; 24(1):52. PubMed ID: 38627828
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A CT-based radiomics nomogram for predicting histologic grade and outcome in chondrosarcoma.
    Li X; Shi X; Wang Y; Pang J; Zhao X; Xu Y; Li Q; Wang N; Duan F; Nie P
    Cancer Imaging; 2024 Apr; 24(1):50. PubMed ID: 38605380
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
    JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combined set7/9 and CDK4 inhibition act synergistically against osteosarcoma.
    Shi Y; Wang Z; Shao Y; Guang Q; Zhang J; Liu B; Wu C; Wang Y; Sui P
    Biochem Biophys Res Commun; 2024 May; 708():149808. PubMed ID: 38520914
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Construction of an oxidative phosphorylation-related gene signature for predicting prognosis and identifying immune infiltration in osteosarcoma.
    Zhou P; Zhang J; Feng J; Wang G
    Aging (Albany NY); 2024 Mar; 16(6):5311-5335. PubMed ID: 38506898
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
    Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
    Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Post Renal Transplant Malignancies; A Basic Concept.
    Nabi Z; Zahid T; Nabi R
    J Ayub Med Coll Abbottabad; 2023; 35(4):664-668. PubMed ID: 38406957
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Parosteal osteosarcoma of the femur and salvage surgery with intercalary prosthesis. Experience in a third level unit and surgical technique].
    Vilchis-Ramírez M; Álvarez-Martínez FA; Tena-Sanabria ME; Fuentes-Herrera G
    Acta Ortop Mex; 2023; 37(5):309-313. PubMed ID: 38382457
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
    Yang W; Liu Z; Liu T
    Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Core outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international Delphi consensus study "PC-COS Children".
    Seylanova N; Chernyavskaya A; Degtyareva N; Mursalova A; Ajam A; Xiao L; Aktulaeva K; Roshchin P; Bobkova P; Aiyegbusi OL; Anbu AT; Apfelbacher C; Asadi-Pooya AA; Ashkenazi-Hoffnung L; Brackel C; Buonsenso D; de Groote W; Diaz JV; Dona D; Dunn Galvin A; Genuneit J; Goss H; Hughes SE; Jones CJ; Kuppalli K; Malone LA; McFarland S; Needham DM; Nekliudov N; Nicholson TR; Oliveira CR; Schiess N; Segal TY; Sigfrid L; Thorne C; Vijverberg S; Warner JO; Were WM; Williamson PR; Munblit D;
    Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38359962
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRAS
    Lin P; Cheng W; Qi X; Zhang P; Xiong J; Li J
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338834
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations.
    Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
    J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Image Biomarker Standardization Initiative: Standardized Convolutional Filters for Reproducible Radiomics and Enhanced Clinical Insights.
    Whybra P; Zwanenburg A; Andrearczyk V; Schaer R; Apte AP; Ayotte A; Baheti B; Bakas S; Bettinelli A; Boellaard R; Boldrini L; Buvat I; Cook GJR; Dietsche F; Dinapoli N; Gabryś HS; Goh V; Guckenberger M; Hatt M; Hosseinzadeh M; Iyer A; Lenkowicz J; Loutfi MAL; Löck S; Marturano F; Morin O; Nioche C; Orlhac F; Pati S; Rahmim A; Rezaeijo SM; Rookyard CG; Salmanpour MR; Schindele A; Shiri I; Spezi E; Tanadini-Lang S; Tixier F; Upadhaya T; Valentini V; van Griethuysen JJM; Yousefirizi F; Zaidi H; Müller H; Vallières M; Depeursinge A
    Radiology; 2024 Feb; 310(2):e231319. PubMed ID: 38319168
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.
    Cai F; Liu L; Bo Y; Yan W; Tao X; Peng Y; Zhang Z; Liao Q; Yi Y
    BMC Cancer; 2024 Feb; 24(1):166. PubMed ID: 38308235
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Role of PAX6, TRPA1, BCL11B, MCOLN2, CUX1, EMX1 in colorectal cancer and osteosarcoma.
    Zhang J; Gao Q; Hou S; Chi X; Zheng M; Zhang Q; Shan H; Zhang X; Kang C
    Medicine (Baltimore); 2024 Feb; 103(5):e37056. PubMed ID: 38306561
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancreatic Cancer.
    Lee MJ; Cho JY; Bae S; Jung HS; Kang CM; Kim SH; Choi HJ; Lee CK; Kim H; Jo D; Paik YK
    J Proteome Res; 2024 Mar; 23(3):985-998. PubMed ID: 38306169
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Quantifying the carbon footprint of clinical trials: guidance development and case studies.
    Griffiths J; Fox L; Williamson PR;
    BMJ Open; 2024 Jan; 14(1):e075755. PubMed ID: 38267250
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through ERK/NFκB axis in Osteosarcoma.
    Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
    Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 76.